These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29098843)

  • 41. [Malaria situation in the People's Republic of China in 2002].
    Sheng HF; Zhou SS; Gu ZC; Zheng X
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2003; 21(4):193-6. PubMed ID: 14628361
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Natural substances in currently available Chinese herbal and patent medicines.
    Hirschhorn HH
    J Ethnopharmacol; 1982 Jul; 6(1):109-19. PubMed ID: 7109662
    [No Abstract]   [Full Text] [Related]  

  • 43. [A survey and analysis of Chinese patent medicine for outpatients with chronic kidney disease].
    Su GB; Liu XS; Weng JX
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Aug; 31(8):1074-9. PubMed ID: 21910338
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Retrospective Study on the Use of Chinese Patent Medicine in 24 Medical Institutions for COVID-19 in China.
    Zhang N; Shi N; Li S; Liu G; Han Y; Liu L; Zhang X; Kong X; Zhang B; Yuan W; Liu Y; Deng D; Zheng M; Zhang Y; Li L; Wang X; Wu J; Lin X; Nian H; Wu X; Wang H; Liu F; Wang H; Wang H; Liu Y; Liu L; Zeng W; Yang M; Wang Y; Zhai H; Wang Y
    Front Pharmacol; 2020; 11():574562. PubMed ID: 33776751
    [No Abstract]   [Full Text] [Related]  

  • 45. Study on industrial selection of counterpart cooperation between Jilin province and Zhejiang province in China from the perspective of low carbon.
    Li D; Lei Y; Li L; Liu L
    Environ Sci Pollut Res Int; 2020 May; 27(14):16668-16676. PubMed ID: 32128735
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Cultivation strategy and path analysis on big brand Chinese medicine for small and medium-sized enterprises].
    Wang YY; Yang HJ
    Zhongguo Zhong Yao Za Zhi; 2014 Mar; 39(5):755-8. PubMed ID: 25204160
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Guidance of instructions for compiling expert consensus on clinical practice of Chinese patent medicine of China Association of Chinese Medicine].
    Mo M; Zhang XX; Liao X; Li B; Chen W; Zhao GZ; Guo YB
    Zhongguo Zhong Yao Za Zhi; 2019 Jun; 44(12):2652-2656. PubMed ID: 31359736
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chinese patent medicine as a potential source of mercury poisoning.
    Kang-Yum E; Oransky SH
    Vet Hum Toxicol; 1992 Jun; 34(3):235-8. PubMed ID: 1609495
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Use of the TLC scanning method in the study of the quality of Chinese patent medicines--the quantitative analysis of berberine in 5 Chinese patent medicines].
    Zhou SD
    Zhong Yao Tong Bao; 1985 Jan; 10(1):36-7, 30. PubMed ID: 3157477
    [No Abstract]   [Full Text] [Related]  

  • 50. [Spatial differences of Chinese material medicine resources species in Jilin province].
    Zhang XB; Qiu ZD; Wang H; Jing ZX; Guo LP; Qu XB; Huang LQ
    Zhongguo Zhong Yao Za Zhi; 2017 Nov; 42(22):4336-4340. PubMed ID: 29318831
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Which one is more important, raw materials or productive technology?--a case study for quality consistency control of Gegen Qinlian decoction].
    Zhong W; Chen S; Zhang J; Wang YS; Liu A
    Zhongguo Zhong Yao Za Zhi; 2016 Mar; 41(6):1027-1032. PubMed ID: 28875665
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Analyses on positive influence of harmonous development of traditional Chinese medicine compounds' researchs and patent protection].
    Yang X; Xiao S; Guo Z; Wang Z; You Y
    Zhongguo Zhong Yao Za Zhi; 2012 Jan; 37(1):9-12. PubMed ID: 22741453
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Application of DNA metabarcoding technology in identification of Chinese patent medicines].
    Gao YZ; Wei J; Liu ZW; Zhou J
    Zhongguo Zhong Yao Za Zhi; 2019 Jan; 44(2):261-264. PubMed ID: 30989942
    [TBL] [Abstract][Full Text] [Related]  

  • 54. On-Line two dimensional liquid chromatography based on skeleton type molecularly imprinted column for selective determination of sulfonylurea additive in Chinese patent medicines or functional foods.
    Guo P; Xu X; Chen G; Bashir K; Shu H; Ge Y; Jing W; Luo Z; Chang C; Fu Q
    J Pharm Biomed Anal; 2017 Nov; 146():292-301. PubMed ID: 28903088
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The apprentice education system of Chinese medicinal industry in modern Kunming].
    Yang Z
    Zhonghua Yi Shi Za Zhi; 2015 Jul; 45(4):221-8. PubMed ID: 26815024
    [TBL] [Abstract][Full Text] [Related]  

  • 56. When I use a word . . . Medicines regulation-Patent medicines.
    Aronson JK
    BMJ; 2023 Dec; 383():2854. PubMed ID: 38084416
    [No Abstract]   [Full Text] [Related]  

  • 57. [Development strategy and current situation of Chinese patent medicine for children in China].
    Yang YJ; Zhu MM; Yang B; Jia XB; Feng L
    Zhongguo Zhong Yao Za Zhi; 2022 Nov; 47(21):5681-5688. PubMed ID: 36471986
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Review of taste masking techniques in Chinese patent medicine].
    Xiao Z; Li Z; Sun YY; Lin RQ; Mo XM
    Zhongguo Zhong Yao Za Zhi; 2021 Jan; 46(2):333-339. PubMed ID: 33645119
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Study on sustainable development of industy of ethnic medicine in minority area].
    Ye H; Liu SL; Zhai YS; Huang MJ; Zhang LD
    Zhongguo Zhong Yao Za Zhi; 2014 Aug; 39(16):3176-9. PubMed ID: 25509310
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Technical specifications for post-marketing pharmacoeconomic evaluation of Chinese medicine (draft version for comments)].
    Xie YM; Wang X; Wang N; Chang YP
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):2925-9. PubMed ID: 24471305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.